Among them, TSHR and RNASET2 were highly expressed in malignant tumors, especially TSHR in thyroid cancer, while BACH2, CTLA4, PTPN22, IL2RA, and other immune-related genes are expressed significantly lower in thyroid cancer. This evidence concerns the gene TSHR and thyroid gland carcinoma.